Dural graft-associated Creutzfeldt-Jakob Disease (Q87908): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:57, 15 August 2026
Dural graft-associated Creutzfeldt-Jakob Disease (dCJD) developed in patients transplanted with human cadaveric dura that had the "infectious" prion. It was first described in 1972 and later has been reported mainly in Japan. After the special chemical treatments of the dura and prohibition of use of cadaveric dura in general, dCJD occurrence has dramatically decreased in subsequent years.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_70256049 |
||
| English | Dural graft-associated Creutzfeldt-Jakob Disease |
Dural graft-associated Creutzfeldt-Jakob Disease (dCJD) developed in patients transplanted with human cadaveric dura that had the "infectious" prion. It was first described in 1972 and later has been reported mainly in Japan. After the special chemical treatments of the dura and prohibition of use of cadaveric dura in general, dCJD occurrence has dramatically decreased in subsequent years. |
Statements
CID11:ID_70256049
0 references
dki-india-ID_70256049
0 references
Concluído
0 references
13 August 2026
0 references
